Filing Details

Accession Number:
0001127602-12-013037
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-04-03 13:00:00
Reporting Period:
2012-04-01
Filing Date:
2012-04-03
Accepted Time:
2012-04-03 18:02:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
884731 Ariad Pharmaceuticals Inc ARIA Biological Products, (No Disgnostic Substances) (2836) 223106987
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1542768 E Maria Cantor C/O Ariad Pharmaceuticals, Inc.
26 Landsdowne Street
Cambridge MA 02139
Svp, Corporate Affairs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-04-01 8,500 $0.00 36,727 No 4 M Direct
Common Stock Disposition 2012-04-03 3,400 $16.18 33,327 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2012-04-01 8,500 $0.00 8,500 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
17,000 2021-04-01 No 4 M Direct
Footnotes
  1. Shares were acquired upon vesting of restricted stock units awarded on April 1, 2011.
  2. Represents shares sold to satisfy withholding tax requirements.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.06 to $16.32, inclusive. The reporting person undertakes to provide to ARIAD Pharmaceuticals, Inc. ("ARIAD"), any security holder of ARIAD, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.
  4. Each restricted stock unit represents a right to receive one share of ARIAD common stock.
  5. Restricted stock units awarded on April 1, 2011 vest as to 33-1/3% of the award on each of April 1, 2012, April 1, 2013, and April 1, 2014.